<p>(A) Heat map of microarray analysis depicting the expression levels of the mRNAs of 7 genes that are significantly upregulated in the TIC population compared with the three other non-TIC populations. RNA was prepared from the four FACS-sorted populations of primary MMTV-PyMT breast tumors. Red and green indicate high and low mRNA expression levels, respectively. The expression values were normalized by Z score. (B) The expression levels of the mRNAs of 7 genes in TICs and non-TICs, as determined by quantitative real-time PCR. cDNA isolated from non-TICs was used to normalize data for each primer of gene and generate RQ (relative quantity). (C) The expression levels FGFR2 protein in the subpopulations by flow cytometry. This figure repres...
The objective of this study was to determine diff erential expression of TFF1, TFF2 and TFF3 genes a...
a) As in previous figures, the star indicates the significant cell types after Bonferroni correction...
Breast cancer is the 2nd most common cancer globally with nearly 1.7 million new cases of all cancer...
<p>(A) The expression levels of FGFR2 mRNA in patient-derived breast tumors. Quantitative real-time ...
<p>(A) Flow cytometry analysis of CD24 and CD29 expression for TIC and non-TIC subpopulation frequen...
<p>Isoforms FGFR2-IIIb and FGFR2-IIIc differ in exon 8, resulting in a variation of 3 bp in length o...
Breast cancers today are of predominantly T1 (0.1 ≥ 2.0 cm) or T2 (>2 ≤ 5 cm) categories due to earl...
The goal of improving systemic treatment of breast cancers is to evolve from treating every patient ...
As transforming growth factor betas (TGF?s) are of potential importance in the natural history of br...
<div><p>Emerging evidence suggests that some cancers contain a population of stem-like TICs (tumor-i...
Emerging evidence suggests that some cancers contain a population of stem-like TICs (tumor-initiatin...
Emerging evidence suggests that some cancers contain a population of stem-like TICs (tumor-initiatin...
<p>A) First two principal components derived from RefSeq gene RNAseq FPKM expression levels. As expe...
BACKGROUND: Diagnosis and prognosis in breast cancer are mainly based on histology and immunohistoch...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
The objective of this study was to determine diff erential expression of TFF1, TFF2 and TFF3 genes a...
a) As in previous figures, the star indicates the significant cell types after Bonferroni correction...
Breast cancer is the 2nd most common cancer globally with nearly 1.7 million new cases of all cancer...
<p>(A) The expression levels of FGFR2 mRNA in patient-derived breast tumors. Quantitative real-time ...
<p>(A) Flow cytometry analysis of CD24 and CD29 expression for TIC and non-TIC subpopulation frequen...
<p>Isoforms FGFR2-IIIb and FGFR2-IIIc differ in exon 8, resulting in a variation of 3 bp in length o...
Breast cancers today are of predominantly T1 (0.1 ≥ 2.0 cm) or T2 (>2 ≤ 5 cm) categories due to earl...
The goal of improving systemic treatment of breast cancers is to evolve from treating every patient ...
As transforming growth factor betas (TGF?s) are of potential importance in the natural history of br...
<div><p>Emerging evidence suggests that some cancers contain a population of stem-like TICs (tumor-i...
Emerging evidence suggests that some cancers contain a population of stem-like TICs (tumor-initiatin...
Emerging evidence suggests that some cancers contain a population of stem-like TICs (tumor-initiatin...
<p>A) First two principal components derived from RefSeq gene RNAseq FPKM expression levels. As expe...
BACKGROUND: Diagnosis and prognosis in breast cancer are mainly based on histology and immunohistoch...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
The objective of this study was to determine diff erential expression of TFF1, TFF2 and TFF3 genes a...
a) As in previous figures, the star indicates the significant cell types after Bonferroni correction...
Breast cancer is the 2nd most common cancer globally with nearly 1.7 million new cases of all cancer...